Roche's Sequencing Sales Decline 15 Percent in Q1

The year-over-year decline in first-quarter sequencing revenues follows a year of stagnation: for full-year 2009, Roche's Applied Science group reported flat overall sales for DNA sequencing systems, though sequencing reagent sales were up 26 percent.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.